Voltaren Emulgel

Land: Armenia

Språk: engelsk

Kilde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktiv ingrediens:

diclofenac (diclofenac diethylamine)

Tilgjengelig fra:

Novartis Consumer Health S.A.

INN (International Name):

diclofenac (diclofenac diethylamine)

Dosering :

10mg/g

Legemiddelform:

gel for external use

Resept typen:

OTC

Preparatomtale

Novartis Consumer Health
Global Regulatory Affairs
Global Labeling
VOLTAREN EMULGEL
Gel
Diclofenac diethylamine 1.16%
SMPC
The National Product Information (and Regional Product Information) is
based on the SmPC.
However, because national regulatory requirements and medical
practices vary between countries,
the National (and Regional) Product Information may differ in several
respects, including but not
limited to the Core Safety Information.
Author(s):
Babu Selvam
Document status:
FINAL
GLC approval date:
02 Dec 2010, 29 Sep 2011
GLC tracking ID:
2010 Dec 02/06-N, 2011-Sep-29/04-N
Amendment date(s):
3 Dec 2009, 17 Jun 2010, 18 Nov 2010, 02 Dec 2010, 29 Sep 2011
Effective date:
05 Oct 2011
Next update date:
Sep 2014
Number of pages:
7
Property of Novartis Consumer Health
Novartis
CONFIDENTIAL
Page 2
Voltaren DEA 1.16% range
TABLE OF CONTENTS
1
NAME OF THE MEDICINAL PRODUCT
.......................................................................3
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
.............................................3
3
PHARMACEUTICAL
FORM............................................................................................3
4
CLINICAL PARTICULARS
..............................................................................................3
4.1
Therapeutic
indications............................................................................................3
4.2
Posology and method of administration
..................................................................3
4.3
Contraindications
.....................................................................................................
4
4.4
Special warnings and precautions for
use................................................................4
4.5
Interaction with other medicinal products and other forms of
interaction ..............4
4.6
Pregnancy and
lactation...........................................................................................4
4.7
Effects on ability to drive and use machines
....................................